Shu-Wen Kuo

Title: Innovations of Shu-Wen Kuo in Pharmaceutical Formulations

Introduction

Shu-Wen Kuo is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of extended-release medications. With a total of four patents to his name, Kuo's work focuses on enhancing the efficacy and duration of drug action.

Latest Patents

One of Kuo's latest patents involves pharmaceutical formulations for the sustained release of sebacoyl dinalbuphine ester. This invention relates to injectable, extended-release pharmaceutical formulations that comprise a nalbuphine ester prodrug homogenously dissolved in a solution containing a pharmaceutically acceptable oil and an oil-miscible retaining solvent. The patent also outlines manufacturing processes and medical uses for these formulations. Additionally, it provides methods for adjusting the duration of action by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.

Career Highlights

Throughout his career, Shu-Wen Kuo has worked with prominent companies in the pharmaceutical industry, including Lumosa Therapeutics Co., Ltd and Shanghai Lumosa Therapeutics Co., Ltd. His experience in these organizations has allowed him to develop innovative solutions that address critical medical needs.

Collaborations

Kuo has collaborated with several professionals in his field, including Chan-Jung Li and David Chih-Kuang Chou. These partnerships have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Shu-Wen Kuo's contributions to pharmaceutical formulations demonstrate his commitment to innovation in the medical field. His work continues to impact the development of effective drug delivery systems, enhancing patient care and treatment outcomes.